ArticleFrontiers in immunology2023

Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments.

Roald Pfannes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.